From the Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, P. R. China (G.Z., Y.F., Z.C., F.Y., Z.G., R.D., W.K.); and BHF Centre, School of Cardiovascular Medicine & Science, King's College London, United Kingdom (Y.H., L.Z., Q.X.).
Circ Res. 2017 Dec 8;121(12):1331-1345. doi: 10.1161/CIRCRESAHA.117.311450. Epub 2017 Oct 31.
Although not fully understood, the phenotypic transition of vascular smooth muscle cells exhibits at the early onset of the pathology of aortic aneurysms. Exploring the key regulators that are responsible for maintaining the contractile phenotype of vascular smooth muscle cells (VSMCs) may confer vascular homeostasis and prevent aneurysmal disease. XBP1 (X-box binding protein 1), which exists in a transcriptionally inactive unspliced form (XBP1u) and a spliced active form (XBP1s), is a key component in response to endoplasmic reticular stress. Compared with XBP1s, little is known about the role of XBP1u in vascular homeostasis and disease.
We aim to investigate the role of XBP1u in VSMC phenotypic switching and the pathogenesis of aortic aneurysms.
XBP1u, but not XBP1s, was markedly repressed in the aorta during the early onset of aortic aneurysm in both angiotensin II-infused apolipoprotein E knockout (ApoE) and CaPO (calcium phosphate)-induced C57BL/6J murine models, in parallel with a decrease in smooth muscle cell contractile apparatus proteins. In vivo studies revealed that XBP1 deficiency in smooth muscle cells caused VSMC dedifferentiation, enhanced vascular inflammation and proteolytic activity, and significantly aggravated both thoracic and abdominal aortic aneurysms in mice. XBP1 deficiency, but not an inhibition of XBP1 splicing, induced VSMC switching from the contractile phenotype to a proinflammatory and proteolytic phenotype. Mechanically, in the cytoplasm, XBP1u directly associated with the N terminus of FoxO4 (Forkhead box protein O 4), a recognized repressor of VSMC differentiation via the interaction and inhibition of myocardin. Blocking the XBP1u-FoxO4 interaction facilitated nuclear translocation of FoxO4, repressed smooth muscle cell marker genes expression, promoted proinflammatory and proteolytic phenotypic transitioning in vitro, and stimulated aortic aneurysm formation in vivo.
Our study revealed the pivotal role of the XBP1u-FoxO4-myocardin axis in maintaining the VSMC contractile phenotype and providing protection from aortic aneurysm formation.
尽管尚未完全阐明,但血管平滑肌细胞的表型转化在主动脉瘤病理学的早期就已经出现。探索负责维持血管平滑肌细胞(VSMC)收缩表型的关键调节因子,可能有助于血管维持内稳态并预防动脉瘤疾病。XBP1(X 盒结合蛋白 1)以转录非活性的未剪接形式(XBP1u)和剪接活性形式(XBP1s)存在,是应对内质网应激的关键组成部分。与 XBP1s 相比,人们对 XBP1u 在血管维持内稳态和疾病中的作用知之甚少。
我们旨在研究 XBP1u 在 VSMC 表型转换和主动脉瘤发病机制中的作用。
在血管紧张素 II 输注载脂蛋白 E 敲除(ApoE)和 CaPO(磷酸钙)诱导的 C57BL/6J 小鼠模型主动脉瘤早期,XBP1u 而非 XBP1s 在主动脉中明显受到抑制,同时平滑肌细胞收缩装置蛋白减少。体内研究表明,平滑肌细胞中 XBP1 的缺失导致 VSMC 去分化,增强血管炎症和蛋白水解活性,并显著加重小鼠的胸主动脉和腹主动脉瘤。XBP1 缺失,但不是 XBP1 剪接的抑制,诱导 VSMC 从收缩表型向促炎和蛋白水解表型转换。从机制上讲,在细胞质中,XBP1u 直接与 FoxO4(叉头框蛋白 O4)的 N 端结合,FoxO4 是通过与肌球蛋白相互作用和抑制来抑制 VSMC 分化的公认抑制剂。阻断 XBP1u-FoxO4 相互作用促进了 FoxO4 的核转位,抑制了平滑肌细胞标记基因的表达,促进了体外促炎和蛋白水解表型的转化,并刺激了体内主动脉瘤的形成。
我们的研究揭示了 XBP1u-FoxO4-肌球蛋白轴在维持 VSMC 收缩表型和提供保护免受主动脉瘤形成中的关键作用。